-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Downgrades QuidelOrtho to Neutral, Lowers Price Target to $33

Benzinga·10/07/2025 11:25:09
Listen to the news
Citigroup analyst Patrick Donnelly downgrades QuidelOrtho (NASDAQ:QDEL) from Buy to Neutral and lowers the price target from $40 to $33.